BE901016A - Ester benzoyloxymethylique de la norfloxacine, sa preparation et son utilisation. - Google Patents
Ester benzoyloxymethylique de la norfloxacine, sa preparation et son utilisation. Download PDFInfo
- Publication number
- BE901016A BE901016A BE0/213978A BE213978A BE901016A BE 901016 A BE901016 A BE 901016A BE 0/213978 A BE0/213978 A BE 0/213978A BE 213978 A BE213978 A BE 213978A BE 901016 A BE901016 A BE 901016A
- Authority
- BE
- Belgium
- Prior art keywords
- fluoro
- acid
- ester
- preparation
- oxo
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 150000002148 esters Chemical class 0.000 title claims abstract description 5
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 title description 9
- 229960001180 norfloxacin Drugs 0.000 title description 7
- -1 1-ethyl-6-fluoro-7- (1-piperazinyl) -4-oxo-1,4-dihydro-quinoline-3-carboxylic acid benzoyloxymethyl ester Chemical compound 0.000 claims abstract description 9
- 150000001875 compounds Chemical class 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- LAZQWLMVJAIYFE-UHFFFAOYSA-N 1-tritylpiperazine Chemical compound C1CNCCN1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 LAZQWLMVJAIYFE-UHFFFAOYSA-N 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 3
- WNNSMMJBBOPPOT-UHFFFAOYSA-N 7-chloro-1-ethyl-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound FC1=C(Cl)C=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 WNNSMMJBBOPPOT-UHFFFAOYSA-N 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- BOXZXICVMMSYPE-UHFFFAOYSA-N chloromethyl benzoate Chemical compound ClCOC(=O)C1=CC=CC=C1 BOXZXICVMMSYPE-UHFFFAOYSA-N 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims 3
- 239000000370 acceptor Substances 0.000 claims 1
- 230000001476 alcoholic effect Effects 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 239000012442 inert solvent Substances 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 4
- 239000003242 anti bacterial agent Substances 0.000 abstract description 2
- 208000019206 urinary tract infection Diseases 0.000 abstract description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- MSQACBWWAIBWIC-UHFFFAOYSA-N hydron;piperazine;chloride Chemical compound Cl.C1CNCCN1 MSQACBWWAIBWIC-UHFFFAOYSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 150000004885 piperazines Chemical class 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000006642 detritylation reaction Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- LZTRCELOJRDYMQ-UHFFFAOYSA-N triphenylmethanol Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(O)C1=CC=CC=C1 LZTRCELOJRDYMQ-UHFFFAOYSA-N 0.000 description 1
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT23663/83A IT1194455B (it) | 1983-11-10 | 1983-11-10 | Chemioterapico ad azione protatta |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE901016A true BE901016A (fr) | 1985-03-01 |
Family
ID=11208987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/213978A BE901016A (fr) | 1983-11-10 | 1984-11-08 | Ester benzoyloxymethylique de la norfloxacine, sa preparation et son utilisation. |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE901016A (it) |
| ES (1) | ES8600638A1 (it) |
| IT (1) | IT1194455B (it) |
| ZA (1) | ZA848782B (it) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2380567A4 (en) * | 2008-12-22 | 2014-04-09 | Pola Chem Ind Inc | MEANS FOR SUPPRESSING MELANINE PRODUCTION |
-
1983
- 1983-11-10 IT IT23663/83A patent/IT1194455B/it active
-
1984
- 1984-11-08 BE BE0/213978A patent/BE901016A/fr not_active IP Right Cessation
- 1984-11-09 ES ES537810A patent/ES8600638A1/es not_active Expired
- 1984-11-09 ZA ZA848782A patent/ZA848782B/xx unknown
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2380567A4 (en) * | 2008-12-22 | 2014-04-09 | Pola Chem Ind Inc | MEANS FOR SUPPRESSING MELANINE PRODUCTION |
| US8846012B2 (en) | 2008-12-22 | 2014-09-30 | Pola Chemical Industries Inc. | Melanin production inhibitor |
| AU2009331298B2 (en) * | 2008-12-22 | 2015-04-30 | Pola Chemical Industries Inc. | Melanin production inhibitor |
Also Published As
| Publication number | Publication date |
|---|---|
| ES537810A0 (es) | 1985-10-16 |
| IT8323663A1 (it) | 1985-05-10 |
| IT8323663A0 (it) | 1983-11-10 |
| ZA848782B (en) | 1985-07-31 |
| ES8600638A1 (es) | 1985-10-16 |
| IT1194455B (it) | 1988-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH679582A5 (it) | ||
| FR2532843A1 (fr) | Composition pharmaceutique comprenant a titre de principe actif le phytol ou l'isophytol | |
| EP0556872A1 (fr) | Utilisation de dérivés du diméthyl-2,2 chromène dans le traitement de l'asthme | |
| KR20040089106A (ko) | 벤즈아제핀 화합물의 고체 염 및 약제학적 화합물의제조에서 이의 용도 | |
| BE897617A (fr) | Thioesters d'acide acetylsalicylique procede pour les preparer et compositions pharmaceutiques qui en renferment | |
| BE901016A (fr) | Ester benzoyloxymethylique de la norfloxacine, sa preparation et son utilisation. | |
| EP1230252B1 (fr) | Derives de beta-d-5-thioxylose, procede de preparation et utilisation en therapeutique | |
| FR2515038A1 (fr) | A titre de medicaments, certains derives de l'acide 4-phenyl 4-oxo 2-butenoique et compositions les renfermant | |
| EP0772630B1 (fr) | Derives de streptogramine, leur preparation et les compositions pharmaceutiques qui les contiennent | |
| MC1914A1 (fr) | Nucleosides therapeutiques | |
| CA2086925C (fr) | Sels derives de la dialcoylaminoalcoylsulfonyl-26 pristinamycine iib | |
| CH637650A5 (fr) | Procede de preparation d'un acide chromone carboxylique. | |
| MC1287A1 (fr) | Derives de cyclohexadiene | |
| CH645115A5 (fr) | Procede pour preparer la chloro-7 methyl-2 dihydro-3,3a 2h,9h-isoxazolo(3,2-b)(benzoxazine-1,3)one-9. | |
| EP0040433B1 (en) | Nicotinic derivatives of glucosamine, process for their preparation and related pharmaceutical compositions | |
| FR2531084A1 (fr) | Nouveaux derives de la 7-(4-pyridyl)-1,8-naphtyridine, medicament et compositions pharmaceutiques en contenant | |
| WO1985005103A1 (fr) | Derives sulfures de l'hydantoine et compositions pharmaceutiques les contenant | |
| FR2624120A1 (fr) | Nouveaux sels organogermaniques utiles comme medicaments notamment comme activateurs des osteoblastes | |
| CH627368A5 (en) | S,S'-Decamethylene-1,10-dimercapto derivatives which are useful as normolipidaemic medicaments | |
| EP0151052A2 (fr) | Aminoéthylimidazole, composition pharmaceutique en contenant et procédé de préparation | |
| BE900370R (fr) | 4-carbamoyloxy-oxazaphosphorines, procede pour leur fabrication et preparations pharmaceutiques contenant celles-ci. | |
| KR840001621B1 (ko) | 글루코사민의 니코틴산유도체의 제조방법 | |
| BE879436A (fr) | 2,6-diaminonebularines, leur preparation et leur utilisation | |
| BE881677A (fr) | Nouveaux derives d'acide penicillanique utile notamment comme antibiotiques et leurs procedes de preparation | |
| BE884978A (fr) | Nouveaux esters de l'acide benzoique substitue |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: PULITZER ITALIANA S.P.A. Effective date: 19931130 |